Bio: Dr. Sellmeyer is an internationally recognized expert in Metabolic Bone Disease. She is a renowned clinician who joined the Stanford faculty in 2018 as a Professor of Medicine. She has been recognized for her clinical excellence with induction into the Miller Coulson Academy of Clinical Excellence while she was at Johns Hopkins. In addition to her clinical expertise, Dr. Sellmeyer maintains a research program that centers on the effect of nutrition and environmental factors on skeletal metabolism which she has investigated through both smaller CRC-based trials and large multi-center trials. Studies she has conducted have investigated the role of dietary sodium chloride, source of dietary protein (animal, vegetable, dairy, soy), role of dietary potassium and alkaline potassium salts, targeted thoracic exercises on kyphosis, whether structured exercise can prevent bone loss in premenopausal women treated for breast cancer, and studies validating nutritional assessment questionnaires. Her expertise as a clinical researcher has enabled development of a multi-disciplinary translational research team including basic scientists in the orthopedic department, junior faculty members with K grant funding, and basic scientists in the endocrine division to develop translational projects studying the effects of osteoporosis medications on basic elements of skeletal biology utilizing bone biopsies from treated individuals as well as clinical trials of novel therapies for rare bone disorders. Dr. Sellmeyer also is a esteemed educator, having received multiple teaching awards.
- Board Certification: Endocrinology, Diabetes and Metabolism, American Board of Internal Medicine (1998)
- Fellowship: UCSF Endocrinology Fellowship (1998) CA
- Residency: Johns Hopkins Hospital Internal Medicine Residency (1994) MD
- Medical Education: Johns Hopkins University School of Medicine (1991) MD
Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women - The fracture intervention trial
Keegan, T. H. M., Schwartz, A. V., Bauer, D. C., Sellmeyer, D. E., & Kelsey, J. L. (2004). Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women - The fracture intervention trial. DIABETES CARE, 27(7), 1547–53.
A proposed method for assessing plasma hypertonicity in vivo
Stookey, J. D., Burg, M., Sellmeyer, D. E., Greenleaf, J. E., Arieff, A., Van Hove, L., … King, J. C. (2007). A proposed method for assessing plasma hypertonicity in vivo. EUROPEAN JOURNAL OF CLINICAL NUTRITION, 61(1), 143–146.
National Institutes of Health Consensus Development Conference: Lactose Intolerance and Health
Suchy, F. J., Brannon, P. M., Carpenter, T. O., Fernandez, J. R., Gilsanz, V., Gould, J. B., … Wolf, M. A. (2010). National Institutes of Health Consensus Development Conference: Lactose Intolerance and Health. ANNALS OF INTERNAL MEDICINE, 152(12), 792-?
Older women with diabetes have an increased risk of fracture: A prospective study
Schwartz, A. V., Sellmeyer, D. E., Ensrud, K. E., Cauley, J. A., Tabor, H. K., Schreiner, P. J., … Cummings, S. R. (2001). Older women with diabetes have an increased risk of fracture: A prospective study. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 86(1), 32–38.